Share
The pharma industry briefing
The latest news, approvals and clinical trials you need to know about this month
Data:
News in Numbers
Data: News in Numbers
$357bn
In 2019, life sciences dealmaking reached an all time high, breaking the previous record set in 2014
1.4 million
The number of flu vaccines provided in 2018/19 by 9,105 NIAVS in community pharmacies according to the NHS
$100m
AstraZeneca will take a $100m writedown after trials of a heart disease drug Epanova showed it to be ineffective in treating a particular cardiovascular condition
48
The number of new drugs approved by the US Food and Drug Administration in 2019
$3.4bn
The estimated cost of the Global Virome Project a proposal that would provide a “pathway to improve capacity to detect, diagnose, and discover viruses”
Data: News in Numbers
$357bn
In 2019, life sciences dealmaking reached an all time high, breaking the previous record set in 2014
1.4 million
The number of flu vaccines provided in 2018/19 by 9,105 NIAVS in community pharmacies according to the NHS
$100m
AstraZeneca will take a $100m writedown after trials of a heart disease drug Epanova showed it to be ineffective in treating a particular cardiovascular condition
48
The number of new drugs approved by the US Food and Drug Administration in 2019
$3.4bn
The estimated cost of the Global Virome Project a proposal that would provide a “pathway to improve capacity to detect, diagnose, and discover viruses”
Rare disease drugs stand out in 2019’s top-performing pharma stocks
Among top-performing stocks, as determined by the increase in their value from Jan. 1, 2019 through the end of the year, many belonged to drug companies.
Source: QZ
Novartis, Merck and Allergan join Big Pharma's 2020 price-hike parade
So far this month, 471 meds have bigger stickers now than they did a week ago, an update from GoodRx shows.
Source: Fierce Pharma
NHS to pioneer cholesterol-busting jab
A twice-a-year injection that reduces bad cholesterol to protect the heart is to be pioneered by the NHS in England.
Source: BBC
Melatonin should not be offered by NHS to treat jet lag
The hormone melatonin should not be available on the NHS to help treat jet lag, a review of the evidence has concluded.
Source: The Guardian
Approvals
Dysport®
The UK’s Medicines and Healthcare Products Regulatory Agency has granted a licence update for Dysport® for the symptomatic treatment of focal spasticity of upper limbs in paediatric cerebral palsy patients, two years of age and older
Source: Ipsen
fremanezumab (Ajovy®)
NHS Scotland has approved Teva’s fremanezumab for the treatment of patients with chronic and episodic migraine who have had prior failure on three or more migraine preventive treatments.
Source: Scottish Medicines Consortium
Valtoco (diazepam)
Valtoco (diazepam) is a nasal spray formulation for the treatment of epilepsy cluster seizures. It was approved by the US FDA in January 2020.
Source: Neurelis
Ayvakit (avapritinib)
The US FDA has approved Ayvakit (avapritinib), a potent and highly selective KIT and PDGFRα inhibitor for the treatment of PDGFRα Exon 18 mutant gastrointestinal stromal tumors (GIST) and fourth-line GIST.
Source: Blue Print Medicines
Go to top
Go to top
Share this article
